HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The expression level of BAALC-associated microRNA miR-3151 is an independent prognostic factor in younger patients with cytogenetic intermediate-risk acute myeloid leukemia.

Abstract
Acute myeloid leukemia (AML) is a heterogeneous disease whose prognosis is mainly related to the biological risk conferred by cytogenetics and molecular profiling. In elderly patients (⩾60 years) with normal karyotype AML miR-3151 have been identified as a prognostic factor. However, miR-3151 prognostic value has not been examined in younger AML patients. In the present work, we have studied miR-3151 alone and in combination with BAALC, its host gene, in a cohort of 181 younger intermediate-risk AML (IR-AML) patients. Patients with higher expression of miR-3151 had shorter overall survival (P=0.0025), shorter leukemia-free survival (P=0.026) and higher cumulative incidence of relapse (P=0.082). Moreover, in the multivariate analysis miR-3151 emerged as independent prognostic marker in both the overall series and within the unfavorable molecular prognostic category. Interestingly, the combined determination of both miR-3151 and BAALC improved this prognostic stratification, with patients with low levels of both parameters showing a better outcome compared with those patients harboring increased levels of one or both markers (P=0.003). In addition, we studied the microRNA expression profile associated with miR-3151 identifying a six-microRNA signature. In conclusion, the analysis of miR-3151 and BAALC expression may well contribute to an improved prognostic stratification of younger patients with IR-AML.
AuthorsM Díaz-Beyá, S Brunet, J Nomdedéu, A Cordeiro, M Tormo, L Escoda, J M Ribera, M Arnan, I Heras, D Gallardo, J Bargay, M P Queipo de Llano, O Salamero, J M Martí, A Sampol, C Pedro, M Hoyos, M Pratcorona, J J Castellano, M Nomdedeu, R M Risueño, J Sierra, M Monzó, A Navarro, J Esteve
JournalBlood cancer journal (Blood Cancer J) Vol. 5 Pg. e352 (Oct 02 2015) ISSN: 2044-5385 [Electronic] United States
PMID26430723 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • BAALC protein, human
  • Biomarkers, Tumor
  • MIRN3151 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
Topics
  • Adolescent
  • Adult
  • Aged
  • Biomarkers, Tumor (genetics)
  • Cytogenetic Analysis
  • Disease-Free Survival
  • Female
  • Humans
  • Kaplan-Meier Estimate
  • Leukemia, Myeloid, Acute (genetics, mortality)
  • Male
  • MicroRNAs (genetics)
  • Middle Aged
  • Neoplasm Proteins (genetics)
  • Prognosis
  • Proportional Hazards Models
  • Risk Factors
  • Transcriptome
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: